- Supported exchanges /
- AU /
- SNT.AU
Syntara Limited (SNT AU) stock market data APIs
Syntara Limited operates as a clinical stage drug development company that focuses on blood-related cancers. Its lead product candidate is PXS-5505, which is in phase 2 trial for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue leading to loss of red and white blood cells and platelets. The company was formerly known as Pharmaxis Ltd and changed its name to Syntara Limited in December 2023. Syntara Limited was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.
Syntara Limited Financial Data Overview
| 0.033 | |
| 0.032 | |
| - | |
| 0.033 | |
| 0.03 | |
| 0.014-0.05 | |
| 34 627 K | |
| 1 194 M | |
| 19 175 K | |
| 0.617 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Syntara Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 19 175 K
- EBITDA -10 458 000
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Syntara Limited Earnings via APIs
- Latest Release 2024-08-30
- EPS/Forecast NaN
Get Syntara Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
